Accenture surveyed 4,000 patients in the US, UK, France, and Germany that had one of three chronic conditions: Rheumatoid Arthritis, Migraine, or Leukemia. This survey shows how actual patients engage with pharma vs. more general surveys that look at the whole population.
There were a number of interesting findings, we are focusing on three:
- Patients prefer online
- Trust continues to be a serious issue
- Patients will share data to improve care
Patients Prefer Online
94% of American patients visit patient websites and 87% get their emails showing how connected these folks are:
Trust an Issue, Especially in US
Patient organizations have higher trust around the world, which makes sense, but when asked who they would engage more with in the future the US patients showed their distain for pharma:
With the right groups, however (spoiler: doctors -Ed.), patients will share data when there is the hope of better treatment:
There are a few more insights in this quick, 15-slide deck. Overall, this research reinforces how pharma is the low character on the totem pole but also shows pharma marketers that patients look to them for critical product information.